Nvidia Corporation's $3.3T market cap reflects its dominance in AI, robotics, and cloud computing. Read why I think NVDA ...
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, and Biosero, a developer of ...
BD and Biosero, announced a framework collaboration agreement to enable and facilitate robotic arm integration with BD flow cytometry instruments to accelerate drug discovery and development.
Traditionally, several steps in a lab’s flow cytometry workflow for drug discovery and development require manual processes. With robotic integration, these steps can become automated.
MaxCyte Inc. (NASDAQ: MXCT) is a global developer of next-generation cell therapies. They provide crucial technology for cell ...